The Indian Journal of Pediatrics

, Volume 79, Issue 1, pp 43–47 | Cite as

Magnesium Sulfate Tocolysis and Intraventricular Hemorrhage in Very Preterm Infants

Original Article

Abstract

Objective

To estimate the contributory effect of tocolytic magnesium sulfate (MgSO4) exposure to intraventricular hemorrhage (IVH) in preterm infants born at 23–31 wks gestation to mothers without evidence of pregnancy induced hypertension and/or preeclampsia.

Methods

Cases with IVH and controls without IVH were selected from a population-based cohort of preterm infants admitted from January 2004 through May 2008 to the Level III Neonatal Intensive Care Unit (NICU) at Robert Wood Johnson University Hospital. Cases and controls were matched primarily by exact gestational age in completed weeks and secondarily by the birth weight that was same or similar (+/−100 g). The odds of tocolytic MgSO4 exposure among the cases and controls was tested in a regression model to control the difference in demographic and clinical factors between the IVH cases (IVH+) and controls without IVH (IVH-).

Results

Eighty-nine IVH cases and 89 controls were comparable for parity, mode of delivery, antenatal corticosteroid exposure, and surfactant administration. IVH cases were less likely to have preterm premature rupture of membranes and were more likely to be born with low Apgar scores and require ventilation. Among the IVH cases, 30.3% of infants were exposed to tocolytic MgSO4 as compared to 47.2% of controls (Odds Ratio adjusted 0.471, 95% Confidence Interval 0.241, 0.906).

Conclusions

Among the preterm born infants with gestational age 23–31 wks and IVH, tocolytic MgSO4 exposure was less likely to be observed than in neonates with similar clinical characteristics but without IVH, thereby suggesting that antenatal exposure to MgSO4 may have a protective effect against IVH.

Keywords

Preterm neonates Intraventricular hemorrhage Magnesium sulfate tocolysis 

Notes

Acknowledgements

The authors would like to thank Mayoor Bhatt, Aileen Arriola, Richard Ruben, and Rohan Alaigh for their help in the data extraction.

Conflict of Interest

None.

Role of Funding Source

This study was supported in part by a grant from the Memorial Research Fund.

References

  1. 1.
    Fox NS, Gelber SE, Kalish RB, Chasen ST. Contemporary practice patterns and beliefs regarding tocolysis among U.S. Maternal-Fetal-Medicine Specialists. Obstet Gynecol. 2008;112:42–7.PubMedCrossRefGoogle Scholar
  2. 2.
    Lewis DF. Magnesium sulfate: the first-line tocolytic. Obstet Gynecol Clin North Am. 2005;32:485–500.PubMedCrossRefGoogle Scholar
  3. 3.
    Mittendorf R, Pryde PG. A review of the role for magnesium sulfate in preterm labor. BJOG. 2005;11:84–8.Google Scholar
  4. 4.
    Mittendorf R, Dambrosia J, Pryde PG, et al. Association between the use of antenatal magnesium sulfate in preterm labor and adverse health outcomes in infants. Am J Obstet Gynecol. 2002;18:1111–8.CrossRefGoogle Scholar
  5. 5.
    Mittendorf R, Dambrosia J, Dammann O, et al. Association between maternal serum ionized magnesium levels at delivery and neonatal intraventricular hemorrhage. J Pediatr. 2002;140:540–6.PubMedCrossRefGoogle Scholar
  6. 6.
    Mittendorf R, Besinger R, Santillan M, Gianopoulos J. When used in the circumstance of preterm labor, is there a paradoxical effect of varying exposures to magnesium sulfate (MgSO4) on the developing human brain? Am J Obstet Gynecol. 2005;193:S65.CrossRefGoogle Scholar
  7. 7.
    Nelson KB, Grether JK. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics. 1995;95:263–9.PubMedGoogle Scholar
  8. 8.
    Boyle CA, Yeargin-Allsopp MM, Schendel DE, Holmgreen P, Oakley GP. Tocolytic magnesium sulfate exposure and risk of cerebral palsy among children with birth weights less than 1,750 grams. Am J Epidemiol. 2000;52:120–4.CrossRefGoogle Scholar
  9. 9.
    Schendel DE, Berg CJ, Yeargin M, Boyle CA, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA. 1996;276:1805–10.PubMedCrossRefGoogle Scholar
  10. 10.
    Grether JK, Hoogstrate J, Walsh-Greene E, Nelson KB. Magnesium sulfate for tocolysis and risk of spastic cerebral palsy in premature children born to women without preeclampsia. Am J Obstet Gynecol. 2000;183:717–25.PubMedCrossRefGoogle Scholar
  11. 11.
    Paneth N, Jetton J, Pinto-Martin J, Susser M. Magnesium sulfate in labor and risk of neonatal brain lesions and cerebral palsy in low birth weight infants. Pediatrics. 1997;99:E1.PubMedCrossRefGoogle Scholar
  12. 12.
    Rouse DJ, Hirtz DG, Thom E, Varner MW, Spong CY, Mercer BM, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. New Eng J Med. 2008;359:895–905.PubMedCrossRefGoogle Scholar
  13. 13.
    Marret S, Marpeau L, Follet-Bouhamed C, Cambonie G, Astruc D, Delaporte B, et al. Effect of magnesium sulphate on mortality and neurologic morbidity of the very-preterm newborn (old less than 33 weeks) with two-year neurological outcome: results of the prospective PREMAG trial. Gynecol Obstet Fertil. 2008;36:278–88.PubMedCrossRefGoogle Scholar
  14. 14.
    Crowther CA, Hiller JE, Doyle LW, Haslam RR, for the Australasian Collaborative Trial of Magnesium Sulphate (ACTOMgSO4) Collaborative Group. Effect of magnesium sulfate given for neuroprotection before preterm birth: a randomized controlled trial. JAMA. 2003;290:2669–76.PubMedCrossRefGoogle Scholar
  15. 15.
    American College of Obstetrics and Gynecology, Task Force on Neonatal Encephalopathy and Cerebral Palsy, American Academy of Pediatrics. Neonatal encephalopathy and cerebral palsy: defining the pathogenesis and pathophysiology. Washington: American College of Obstetricians and Gynecologists; 2003.Google Scholar
  16. 16.
    Roland EH, Hill A. Germinal matrix-intraventricular hemorrhage in the premature newborn management and outcomes. Neurol Clin. 2003;21:833–51.PubMedCrossRefGoogle Scholar
  17. 17.
    Beall MH, Edgar BW, Paul RH, Smith-Wallace T. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. Am J Obstet Gynecol. 1985;153:854–9.PubMedGoogle Scholar
  18. 18.
    Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage a study of infants with birthweights less than 1500 g. J Pediatr. 1978;92:529–34.PubMedCrossRefGoogle Scholar
  19. 19.
    Volpe JJ. Intracranial hemorrhage: germinal matrix- intraventricular hemorrhage of the premature infant. Neurology of the Newborn. 5th ed. Philadelphia: Saunders Elsevier; 2008. p. 517–88.Google Scholar
  20. 20.
    Colton CA, Gilbert DL. Microglia, an in vivo source of reactive oxygen species in the brain. Adv Neurol. 1993;59:321–6.PubMedGoogle Scholar
  21. 21.
    Ma S, Li X, Fang Q, Rose MG, Chao CR. Influence of fetal to neonatal transition on nitric oxide synthase expression in the nucleus tractus solitarius in sheep. Brain Res Dev. 1999;118:119–27.CrossRefGoogle Scholar
  22. 22.
    McCrea HJ, Ment LR. The diagnosis, management, and postnatal prevention of intraventricular hemorrhage in the preterm neonate. Clin Perinatol. 2008;35:777–92.PubMedCrossRefGoogle Scholar
  23. 23.
    Folkerth RD, Haynes RL, Borenstein NS, et al. Developmental lag in superoxide dismutases relative to other antioxidant enzymes in premyelinated telencephalic white matter. J Neuropathol Exp Neurol. 2004;63:990–9.PubMedGoogle Scholar
  24. 24.
    Golan H, Kashtuzki I, Hallak M, Sorokin Y, Huleihel M. Maternal hypoxia during pregnancy induces fetal neurodevelopmental brain damage: partial protection by magnesium sulfate. J Neurosci Res. 2004;78:430–41.PubMedCrossRefGoogle Scholar
  25. 25.
    Gulczynska E, Gadzinowski J, Wilczynski J, Zylinska L. Prenatal MgSO4 treatment modifies the erythrocyte band 3 in preterm neonates. Pharm Res. 2006;53:347–52.CrossRefGoogle Scholar
  26. 26.
    Sameshima H, Ikenoue T. Long-term magnesium sulfate treatment as protection against hypoxi-ischemic brain injury in seven-day-old rats. Am J Obstet Gynecol. 2001;184:185–90.PubMedCrossRefGoogle Scholar
  27. 27.
    Thordstein M, Bågenholm R, Thiringer K, Kjellmer I. Scavengers of free oxygen radicals in combination with magnesium ameliorate perinatal hypoxic- ischemic brain damage in the rat. Pediatr Res. 1993;34:23–6.PubMedCrossRefGoogle Scholar
  28. 28.
    Turkyilmaz C, Turkyilmaz Z, Atalay Y, Soylemezoglu F, Celasun B. Magnesium pre-treatment reduces neuronal apoptosis in newborn rats in hypoxia-ischemia. Brain Res. 2002;15:133–7.CrossRefGoogle Scholar
  29. 29.
    Gawaz M, Ott I, Reininger AJ, Neumann FJ. Effects of magnesium on platelet aggregation and adhesion: magnesium modulates surface expression of glycoproteins on platelets in vitro and ex vivo. Tromb Haemost. 1994;72:912–8.Google Scholar
  30. 30.
    Hallak M, Berry SM, Madincea F, Romero R, Evans MI, Cotton DB. Fetal serum and amniotic fluid magnesium concentrations with maternal treatment. Obstet Gynecol. 1993;81:185–8.PubMedGoogle Scholar
  31. 31.
    Mason BA, Standley CA, Whitty JE, Cotton DB. Fetal ionized magnesium levels parallel maternal levels during magnesium sulfate for preeclampsia. Am J Obstet Gynecol. 1996;175:213–7.PubMedCrossRefGoogle Scholar
  32. 32.
    Mimouni F, Mughal Z, Hammond G. Placental calcium transport during acute maternal hypermagnesemia in the rat. Am J Obstet Gynecol. 1993;168:984–7.PubMedGoogle Scholar
  33. 33.
    Di Renzo GC, Mignosa M, Gerli S, et al. The combined maternal administration of magnesium sulfate and aminophylline reduces intraventricular hemorrhage in very preterm neonates. Am J Obstet Gynecol. 2005;192:433–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Garnier Y, Middelanis J, Jensen A, Berger R. Neuroprotective effects of magnesium on metabolic disturbances in fetal hippocampal slices after oxygen-glucose deprivation. J Soc Gynecol Investig. 2002;9:86–92.PubMedCrossRefGoogle Scholar
  35. 35.
    David R, Leitch IM, Read MA, Boura ALA, Walters WAW. Actions of magnesium, nifedipine and clonidine on the fetal vasculature of the human placenta. Aust NZ J Obstet Gynecol. 1996;36:267–71.CrossRefGoogle Scholar
  36. 36.
    Mehta R, Petrova A. Ionized magnesium and gestational age. Indian J Pediatr. 2007;74:1025–8.PubMedCrossRefGoogle Scholar

Copyright information

© Dr. K C Chaudhuri Foundation 2011

Authors and Affiliations

  1. 1.Department of Pediatrics, MEB 236UMDNJ-Robert Wood Johnson Medical SchoolNew BrunswickUSA

Personalised recommendations